250 related articles for article (PubMed ID: 18046459)
1. Structure and functional analysis of the IGF-II/IGF2R interaction.
Brown J; Delaine C; Zaccheo OJ; Siebold C; Gilbert RJ; van Boxel G; Denley A; Wallace JC; Hassan AB; Forbes BE; Jones EY
EMBO J; 2008 Jan; 27(1):265-76. PubMed ID: 18046459
[TBL] [Abstract][Full Text] [Related]
2. A novel binding site for the human insulin-like growth factor-II (IGF-II)/mannose 6-phosphate receptor on IGF-II.
Delaine C; Alvino CL; McNeil KA; Mulhern TD; Gauguin L; De Meyts P; Jones EY; Brown J; Wallace JC; Forbes BE
J Biol Chem; 2007 Jun; 282(26):18886-94. PubMed ID: 17475626
[TBL] [Abstract][Full Text] [Related]
3. Computational model for the IGF-II/IGF2r complex that is predictive of mutational and surface plasmon resonance data.
Roche P; Brown J; Denley A; Forbes BE; Wallace JC; Jones EY; Esnouf RM
Proteins; 2006 Aug; 64(3):758-68. PubMed ID: 16741994
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of insulin-like growth factor II (IGF-II) interaction with domain 11 of the human IGF-II/mannose 6-phosphate receptor: function of CD and AB loop solvent-exposed residues.
Zaccheo OJ; Prince SN; Miller DM; Williams C; Kemp CF; Brown J; Jones EY; Catto LE; Crump MP; Hassan AB
J Mol Biol; 2006 Jun; 359(2):403-21. PubMed ID: 16631789
[TBL] [Abstract][Full Text] [Related]
5. Interactions of IGF-II with the IGF2R/cation-independent mannose-6-phosphate receptor mechanism and biological outcomes.
Brown J; Jones EY; Forbes BE
Vitam Horm; 2009; 80():699-719. PubMed ID: 19251056
[TBL] [Abstract][Full Text] [Related]
6. Keeping IGF-II under control: lessons from the IGF-II-IGF2R crystal structure.
Brown J; Jones EY; Forbes BE
Trends Biochem Sci; 2009 Dec; 34(12):612-9. PubMed ID: 19796953
[TBL] [Abstract][Full Text] [Related]
7. Contribution of residues A54 and L55 of the human insulin-like growth factor-II (IGF-II) A domain to Type 2 IGF receptor binding specificity.
Forbe BE; McNeil KA; Scott CD; Surinya KH; Cosgrove LJ; Wallace JC
Growth Factors; 2001; 19(3):163-73. PubMed ID: 11811790
[TBL] [Abstract][Full Text] [Related]
8. An insulin-like growth factor II (IGF-II) affinity-enhancing domain localized within extracytoplasmic repeat 13 of the IGF-II/mannose 6-phosphate receptor.
Devi GR; Byrd JC; Slentz DH; MacDonald RG
Mol Endocrinol; 1998 Nov; 12(11):1661-72. PubMed ID: 9817593
[TBL] [Abstract][Full Text] [Related]
9. Structure of a functional IGF2R fragment determined from the anomalous scattering of sulfur.
Brown J; Esnouf RM; Jones MA; Linnell J; Harlos K; Hassan AB; Jones EY
EMBO J; 2002 Mar; 21(5):1054-62. PubMed ID: 11867533
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of the human Gly1619Arg polymorphism of M6P/IGF2R domain 11 implicated in IGF2 dependent growth.
Rezgui D; Williams C; Savage SA; Prince SN; Zaccheo OJ; Jones EY; Crump MP; Hassan AB
J Mol Endocrinol; 2009 Apr; 42(4):341-56. PubMed ID: 19208780
[TBL] [Abstract][Full Text] [Related]
11. Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor.
Prince SN; Foulstone EJ; Zaccheo OJ; Williams C; Hassan AB
Mol Cancer Ther; 2007 Feb; 6(2):607-17. PubMed ID: 17308058
[TBL] [Abstract][Full Text] [Related]
12. Functional evolution of IGF2:IGF2R domain 11 binding generates novel structural interactions and a specific IGF2 antagonist.
Frago S; Nicholls RD; Strickland M; Hughes J; Williams C; Garner L; Surakhy M; Maclean R; Rezgui D; Prince SN; Zaccheo OJ; Ebner D; Sanegre S; Yu S; Buffa FM; Crump MP; Hassan AB
Proc Natl Acad Sci U S A; 2016 May; 113(20):E2766-75. PubMed ID: 27140600
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of IGF-II/IGF2R recognition: a combined molecular dynamics simulation, free-energy calculation and computational alanine scanning study.
Guo J; Wang X; Sun H; Liu H; Yao X
J Mol Model; 2012 Apr; 18(4):1421-30. PubMed ID: 21761181
[TBL] [Abstract][Full Text] [Related]
14. Disruption of ligand binding to the insulin-like growth factor II/mannose 6-phosphate receptor by cancer-associated missense mutations.
Byrd JC; Devi GR; de Souza AT; Jirtle RL; MacDonald RG
J Biol Chem; 1999 Aug; 274(34):24408-16. PubMed ID: 10446221
[TBL] [Abstract][Full Text] [Related]
15. An exon splice enhancer primes IGF2:IGF2R binding site structure and function evolution.
Williams C; Hoppe HJ; Rezgui D; Strickland M; Forbes BE; Grutzner F; Frago S; Ellis RZ; Wattana-Amorn P; Prince SN; Zaccheo OJ; Nolan CM; Mungall AJ; Jones EY; Crump MP; Hassan AB
Science; 2012 Nov; 338(6111):1209-13. PubMed ID: 23197533
[TBL] [Abstract][Full Text] [Related]
16. Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancer.
Kreiling JL; Montgomery MA; Wheeler JR; Kopanic JL; Connelly CM; Zavorka ME; Allison JL; Macdonald RG
FEBS J; 2012 Aug; 279(15):2695-713. PubMed ID: 22681933
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor II/cation-independent mannose 6-phosphate receptor and lysosomal enzyme recognition.
Dahms NM
Biochem Soc Trans; 1996 Feb; 24(1):136-41. PubMed ID: 8674625
[No Abstract] [Full Text] [Related]
18. The insulin-like growth factor-II/mannose-6-phosphate receptor: structure, distribution and function in the central nervous system.
Hawkes C; Kar S
Brain Res Brain Res Rev; 2004 Mar; 44(2-3):117-40. PubMed ID: 15003389
[TBL] [Abstract][Full Text] [Related]
19. Opposing roles for the insulin-like growth factor (IGF)-II and mannose 6-phosphate (Man-6-P) binding activities of the IGF-II/Man-6-P receptor in the growth of prostate cancer cells.
Schaffer BS; Lin MF; Byrd JC; Park JH; MacDonald RG
Endocrinology; 2003 Mar; 144(3):955-66. PubMed ID: 12586773
[TBL] [Abstract][Full Text] [Related]
20. Altered ligand binding by insulin-like growth factor II/mannose 6-phosphate receptors bearing missense mutations in human cancers.
Devi GR; De Souza AT; Byrd JC; Jirtle RL; MacDonald RG
Cancer Res; 1999 Sep; 59(17):4314-9. PubMed ID: 10485478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
